Major Proposed Sale of $89.1M in BioNTech (BNTX) by Insider Holding Entity Medine GmbH
BioNTech SE
Subscribe to track BNTX
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Form 144 Proposed Sale Alert: BioNTech SE ($BNTX) • Insider: Medine GmbH (Officer & 10% Stockholder, signed by Ugur Sahin) • Shares to Sell: 858,209 ADS • Aggregate Value: $89,090,676.29 (~$103.81/share) • Approx. Sale Date: September 3, 2026 • Broker: Berenberg Capital Markets LLC
Comprehensive Analysis
Insider Filing Analysis: BioNTech SE ($BNTX)
Overview Medine GmbH, an investment entity associated with BioNTech CEO Ugur Sahin (holding officer and 10% stockholder status), has filed a Form 144 notice of proposed sale covering 858,209 American Depositary Shares (ADS) with an estimated market value of $89.09 million.
Key Details
- Filer: Medine GmbH (Signatory: /s/ Ugur Sahin)
- Relationship: Officer / 10% Stockholder
- Proposed Sale Date: September 3, 2026
- Broker: Berenberg Capital Markets LLC
- Securities Origin: Acquired via stock option exercises on November 21, 2022 (856,186 shares) and August 9, 2024 (2,023 shares).
- Past 3 Months Activity: Nothing to report.
Trading Significance This transaction is ranked High due to the substantial dollar value (~$89.1 million) and the prominent insider profile involved.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is AI-generated from public SEC filings and may contain errors. It is for informational and educational purposes only and is not investment, legal, or tax advice.
The Filing Fool is not a registered investment adviser, broker-dealer, or financial planner. Nothing here is a recommendation or solicitation to buy, sell, or hold any security.
Always do your own due diligence and consult a licensed professional.